Depression in cancer patients

European Journal of Cancer, Supplement

Volumn 11, Issue 2, 2013, Pages 205-215

  Dauchy, S ^a   Dolbeault, S ^b   Reich, M ^c  

^a INSTITUT GUSTAVE ROUSSY   (France)

^b INSTITUT CURIE   (France)

^c CENTRE OSCAR LAMBRET   (France)

Author keywords

[No Author keywords available]

Indexed keywords

FLUOXETINE; INTERLEUKIN 2; MIANSERIN; MIRTAZAPINE; PAROXETINE; SEROTONIN NORADRENALIN REUPTAKE INHIBITOR; SEROTONIN UPTAKE INHIBITOR; TAMOXIFEN; TIANEPTINE; TRICYCLIC ANTIDEPRESSANT AGENT; VENLAFAXINE;

AGGRESSIVENESS; BEREAVEMENT; CANCER PATIENT; COMORBIDITY; CONFERENCE PAPER; CONVULSION; DEPRESSION; DYSTHYMIA; EDINBURGH POSTNATAL DEPRESSION SCALE; EMOTIONAL DISORDER; EPILEPTOGENESIS; EXPECTATION; GENERAL HEALTH QUESTIONNAIRE; HORNHEIDE SCREENING INSTRUMENT; HUMAN; HYPERTENSION; HYPONATREMIA; IRRITABILITY; LIVER FAILURE; MENTAL DISEASE; ONCOLOGY; PATIENT CARE; PRIORITY JOURNAL; PROSTATE ADENOMA; PSYCHOMOTOR RETARDATION; PSYCHOSOCIAL WITHDRAWAL; QUALITY OF LIFE; RISK FACTOR; SENSITIVITY AND SPECIFICITY; TREATMENT PLANNING;

EID: 84884911088     PISSN: 13596349     EISSN: 18781217     Source Type: Journal    
DOI: 10.1016/j.ejcsup.2013.07.006     Document Type: Conference Paper

References (65)

1. Chochinov H. Depression in cancer patients. Lancet Oncol 2001, 2:499-505.
2. Fann J.R., Thomas-Rich A.M., et al. Major depression after breast cancer: a review of epidemiology and treatment. Gen Hosp Psychiatry 2008, 30:112-126.
3. Hopko D.R., Bell J.L., et al. The phenomenology and screening of clinical depression in cancer patients. J Psychosoc Oncol 2008, 26:31-51.
4. Spiegel D., Giese-Davis J. Depression and cancer: mechanisms and disease progression. Biol Psychiatry 2003, 54:269-282.
5. Skarstein J., Aass N., Fossa S.D., et al. Anxiety and depression in cancer patients: relation between the hospital anxiety and depression scale and the European Organization for Research and Treatment of Cancer Core Quality of Life Questionnaire. J Psychosom Res 2000, 49:27-34.
6. Gagliese L., Gauthier L.R., et al. Cancer pain and depression: a systematic review of age-related patterns. Pain Res Manage 2007, 12:205-211.
7. Colleoni M., Mandala M., et al. Depression and degree of acceptance of adjuvant cytotoxic drugs. Lancet 2000, 356:1326-1327.
8. Pitceathly C., Maguire P. The psychological impact of cancer on patients' partners and other key relatives: a review. Eur J Cancer 2003, 39(1517-24):1532.
9. Misono S., Weiss N.S., Fann J.R., Redman M., Yueh B. Incidence of suicide in persons with cancer. J Clin Oncol 2008, 26:4705-4707.
10. Prieto J.M., Blanch J., Atala J., et al. Psychiatric morbidity and impact on hospital length of stay among hematologic cancer patients receiving stem-cell transplantation. J Clin Oncol 2002, 20:1907-1917.
11. Satin J.R., Linden W., Phillips M.J. Depression as a predictor of disease progression and mortality in cancer patients.A meta-analysis. Cancer 2009, 115:5349-5361.
12. Chiles J., Lambert M., Hatch A. The impact of psychological interventionson medical cost offset: a meta-analytic review. Clin Psych Sci Pract 1999, 6:204-220.
13. Carlson L.E., Bultz B.D. Efficacy and medical cost offset of psychosocial interventions in cancer care: making the case for economic analyses. Psycho-Oncol 2004, 13:837-849.
14. Mitchell A.J., et al. Prevalence of depression, anxiety, and adjustment disorder in oncological, haematological, and palliative-care settings: a meta-analysis of 94 interview-based studies. Lancet Oncol 2011, 12:160-174.
15. Pirl W.F. Evidence report on the occurrence, assessment ant treatment of depression in cancer patients. JNCI 2004, 32:32-39.
16. Raison C.L., Miller A.H. Depression in cancer: new developments regarding diagnosis and treatment. Biol Psychiatry 2003, 54:283-294.
17. Costanzo E.S., Lutgendorf S.K., et al. Adjusting to life after treatment: distress and quality of life following treatment for breast cancer. Br J Cancer 2007, 97:1625-1631.
18. Montazeri A., Jarvandi S., et al. Anxiety and depression in breast cancer patients before and after participation in a cancer support group. Patient Educ Couns 2001, 45:195-198.
19. Wong-Kim E.C., Bloom J.R. Depression experienced by young women newly diagnosed with breast cancer. Psychooncology 2005, 14:564-573.
20. Rasic D.T., Belik S.L., et al. Cancer, mental disorders, suicidal ideation and attempts in a large community sample. Psychooncology 2008, 17:660-667.
21. Dalton S.O., Schüz J., et al. Social inequality in incidence of and survival from cancer in a population-based study in Denmark, 1994-2003: summary of findings. Eur J Cancer 2008, 44:2074-2085.
22. Ell K., Sanchez K., et al. Depression, correlates of depression, and receipt of depression care among low-income women with breast or gynecologic cancer. J Clin Oncol 2005, 23:3052-3060.
23. Brintzenhofe-Szoc K.M., Levin T.T., Li Y., Kissane D.W., Zabora J.R. Mixed anxiety/depression symptoms in a large cancer cohort: prevalence by cancer type. Psychosomatics 2009, 50:383-391.
24. Ciaramella A., Poly P. Assessment of depression among cancer patients: the role of pain, cancer type and treatment. Psychooncology 2001, 10:156-165.
25. So W.K., Marsh G., Ling W.M., et al. The symptom cluster of fatigue, pain, anxiety, and depression and the effect on the quality of life of women receiving treatment for breast cancer: a multicenter study. Oncol Nurs Forum 2009, 36:205-214.
26. Lee K.C., Ray G.T., et al. Tamoxifen treatment and new-onset depression in breast cancer patients. Psychosomatics 2007, 48:205-210.
27. American Psychiatric Association Diagnostic and statistical manual of mental disorders (DSM IV-R) 1994, Revised, American Psychiatric Association, Washington, DC. Fourth ed.
28. Reuter K., Raugust S., et al. Depressive symptom patterns and their consequences for diagnosis of affective disorders in cancer patients. Support Care Cancer 2004, 12:864-870.
29. Mitchell A.J., et al. Meta-analysis of screening and case finding tools for depression in cancer: evidence based recommendations for clinical practice on behalf of the depression in cancer care consensus group. J Affect Disord 2012, 140:149-160.
30. Mitchell A.J., Lord K., Symons P. Which symptoms are indicative of DSMIV depression in cancer settings? An analysis of the diagnostic significance of somatic and non-somatic symptoms. J Affect Disord 2012, 140:137-148.
31. Endicott J. Measurement of depression in patients with cancer. Cancer 1984; 53: (Suppl):2243-9.
32. Mitchell A.J. Short screening tools for cancer-related distress: a review and diagnostic validity meta-analysis. JNCCN 2010, 8:487-494.
33. Mitchell A.J. Pooled results from 38 analyses of the accuracy of distress thermometer and other ultra-short methods of detecting cancer-related mood disorders. J Clin Oncol 2007, 25:4670-4681.
34. Wedding U., Koch A., et al. Requestioning depression in patients with cancer: contribution of somatic and affective symptoms to Beck's depression inventory. Ann Oncol 2007, 18:1875-1881.
35. Mitchell A.J., Hussain N., Grainger L., Symonds P. Identification of patient-reported distress by clinical nurse specialists in routine oncology practice: a multicentre UK study. Psychooncology 2011, 20:1076-1083.
36. Mitchell A.J. Screening for cancer-related distress: when is implementation successful and when is it unsuccessful?. Acta Oncol 2013, 52:216-224.
37. Hem E., Loge J.H., Haldorsen T., Ekeberg Ø. Suicide risk in cancer patients from 1960 to 1999. J Clin Oncol 2004, 22:4209-4216.
38. Yousaf U., Christensen M.L., Engholm G., Storm H.H. Suicides among Danish cancer patients 1971-1999. Br J Cancer 2005, 92:995-1000.
39. Fisch M. Treatment of depression in cancer. J Natl Cancer Inst Monogr 2004, 32:105-111.
40. Lloyd-Williams M., Dennis M., et al. A prospective study to determine the association between physical symptoms and depression in patients with advanced cancer. Palliat Med 2004, 18:558-563.
41. Montgomery C., Lydon A., et al. Psychological distress among cancer patients and informed consent. J Psychosom Res 1999, 46:241-245.
42. Ell K., et al. Randomized controlled trial of collaborative care management of depression among low-income patients with cancer. J Clin Oncol 2008, 26:4488-4496.
43. Rayner L, et al. Antidepressants for depression in physically ill people. Cochrane review; 2010: issue 4.
44. Musselman D.L., Lawson D.H., et al. Paroxetine for the prevention of depression induced by high-dose interferon alfa. N Engl J Med 2001, 344:961-966.
45. Cipriani A., et al. Comparative efficacy and acceptability of 12 new-generation antidepressants: a multiple-treatments meta-analysis. Lancet 2009, 373:746-758.
46. Holland J.C., Romano S.J., et al. A controlled trial of fluoxetine and desipramine in depressed women with advanced cancer. Psychooncology 1998, 7:291-300.
47. Pezzella G., Moslinger-Gehmayr R., et al. Treatment of depression in patients with breast cancer: a comparison between paroxetine and amitriptyline. Breast Cancer Res Treat 2001, 70:1-10.
48. Musselman D.L., Somerset W.I., et al. A double-blind, multicenter, parallel-group study of paroxetine, desipramine, or placebo in breast cancer patients (stages I, II, III, and IV) with major depression. J Clin Psychiatry 2006, 67:288-296.
49. Rodin G., Lloyd N., et al. The treatment of depression in cancer patients: a systematic review. Support Care Cancer 2007, 15:123-136.
50. Möller H.J. Do SSRIs or antidepressant in general increase suicidality?. Eur Arch Psychiatry Clin Neurosci 2008, 258(Suppl 3):3-23.
51. Coogan P. Review of 2000 the epidemiological literature on antidepressant use and breast cancer risk. Expert Rev Neurother 2006, 6:1363-1374.
52. Boyer E.W., Shannon M. The serotonin syndrome. N Engl J Med 2005, 352:1112-1120.
53. Yap K.Y.-L., Tay W.L., Chui W., Chan A. Clinically relevant drug interactions between anticancer drugs and psychotropic agents. Eur J Cancer Care 2011, 20:6-32.
54. Gilbody S., Bower P., et al. Collaborative care for depression: a cumulative meta-analysis and review of longer-term outcomes. Arch Intern Med 2006, 166:2314-2321.
55. Pampallona S., Bollini P., Tibaldi G., Kupelnick B., Munizza C. Combined pharmacotherapy and psychological treatment for depression: a systematic review. Arch Gen Psychiatry 2004, 61:714-719.
56. Pasquini M., Biondi M. Depression in cancer patients: a critical review. Clin Pract Epidemiol Ment Health 2007, 3:2.
57. Stanton A.L. How and for whom? Asking questions about the utility of psychosocial interventions for individuals diagnosed with cancer. J Clin Oncol 2005, 23:4818-4820.
58. Kissane D.W., Grabsch B., et al. Supportive-expressive group therapy for women with metastatic breast cancer: survival and psychosocial outcome from a randomized controlled trial. Psychooncology 2007, 16:277-286.
59. Boesen E.H., Johansen C. Impact of psychotherapy on cancer survival: time to move on?. Curr Opin Oncol 2008, 20:372-377.
60. Cunningham A.J., Edmonds C.V., et al. A randomized controlled trial of the effects of group psychological therapy on survival in women with metastatic breast cancer. Psychooncology 1998, 7:508-517.
61. Sheard T., Maguire P. The effect of psychological interventions on anxiety and depression in cancer patients: results of two meta-analyses. Br J Cancer 1999, 80:1770-1780.
62. Osborn R.L., Demoncada A.C., Feuerstein M. Psychosocial interventions for depression, anxiety, and quality of life in cancer survivors: meta-analyses. Int J Psychiatry Med 2006, 36:13-34.
63. Blake-Mortimer J., Gore-Felton C., et al. Improving the quality and quantity of life among patients with cancer: a review of the effectiveness of group psychotherapy. Eur J Cancer 1999, 35:1581-1586.
64. Goodwin P.J., Leszcz M., et al. The effect of group psychosocial support on survival in metastatic breast cancer. N Engl J Med 2001, 345:1719-1726.
65. Li M., Fitzgerald P., Rodin G. Evidence-based treatment of depression in patients with cancer. J Clin Oncol 2012, 30:1187-1196.